Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/9575Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mitsios, J. V. | en |
| dc.contributor.author | Papathanasiou, A. I. | en |
| dc.contributor.author | Goudevenos, J. A. | en |
| dc.contributor.author | Tselepis, A. D. | en |
| dc.date.accessioned | 2015-11-24T16:50:10Z | - |
| dc.date.available | 2015-11-24T16:50:10Z | - |
| dc.identifier.issn | 1381-6128 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/9575 | - |
| dc.rights | Default Licence | - |
| dc.subject | atherosclerosis | en |
| dc.subject | coronary artery disease | en |
| dc.subject | platelets | en |
| dc.subject | statins | en |
| dc.subject | thrombosis | en |
| dc.subject | acute coronary syndromes | en |
| dc.subject | low-density-lipoprotein | en |
| dc.subject | soluble cd40 ligand | en |
| dc.subject | dependent thrombin generation | en |
| dc.subject | acute myocardial-infarction | en |
| dc.subject | endothelial nitric-oxide | en |
| dc.subject | coa reductase inhibitors | en |
| dc.subject | hypercholesterolemic patients | en |
| dc.subject | platelet-function | en |
| dc.subject | p-selectin | en |
| dc.title | The Antiplatelet and Antithrombotic Actions of Statins | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | <Go to ISI>://000286877500004 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείας | el |
| heal.publicationDate | 2010 | - |
| heal.abstract | Several studies over the last years have demonstrated that statins exhibit actions beyond that of lipid-lowering (pleiotropic effects) ranging from improving endothelial function, modulating the inflammatory response, maintaining plaque stability and preventing thrombus formation. Since the interplay among platelets, cells and other components of atherosclerotic lesions as well as the coagulation system play an important role in the progression of atherosclerosis and in the development of acute coronary syndromes, these non-lipid properties of statins may help to explain the early and significant reduction of cardiovascular events reported in several clinical trials of statin therapy. This review focuses on the experimental and clinical results regarding the antiplatelet/antithrombotic effects of statins. | en |
| heal.journalName | Curr Pharm Des | en |
| heal.journalType | peer reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
